The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo
about
Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogsBroad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferonThe antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activityNew strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsConsistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses.Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirinManagement of High-risk Corneal Transplantation.Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation.In vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-type and drug-resistant variants of human immunodeficiency virus type 1.The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenaseInhibition of reovirus by mycophenolic acid is associated with the M1 genome segment.Mycophenolic acid inhibits replication of Type 2 Winnipeg, a cerebrospinal fluid-derived reovirus isolate.
P2860
Q28343742-E94BC3F3-AF8D-49E1-B05D-C929A335E10AQ28344042-8BF1C2CE-ABB7-467D-A9A8-4CC071FB4833Q28369328-A2FD12D9-8826-41D0-A31F-9B4C645A0C27Q33781206-453861A7-F67B-4F21-BC24-FBF76CD317FAQ33812425-AC1DBA42-051E-4336-8AA9-937C3C310126Q35076929-D4299EF8-518F-425A-900E-9706EEC7731CQ35941302-C2079CAA-05BF-4365-A4DC-E517E115E31FQ38778422-5E48FEDD-8346-4F38-9C91-0E99D02DABDBQ38904800-89AEA0D0-BAA3-4A4C-BA73-26767CBD253AQ40291210-1DF810AD-1D90-4B0A-A96F-A1B2E842ED69Q40517134-01753F22-AD22-4E95-A877-93D6ADD04F58Q40551606-4E08D8D7-B2D3-4230-89AA-E9167232ECECQ40669336-C4DF886F-069B-4F71-B5FA-E0A0A910159B
P2860
The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@ast
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@en
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@nl
type
label
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@ast
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@en
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@nl
prefLabel
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@ast
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@en
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@nl
P2093
P2860
P1476
The novel immunosuppressive ag ...... nciclovir in vitro and in vivo
@en
P2093
P2860
P304
P407
P577
1998-02-01T00:00:00Z